Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

16 trials with published results (9%)

Research Maturity

92 completed trials (52% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.4%

6 terminated out of 177 trials

Success Rate

93.9%

+7.4% vs benchmark

Late-Stage Pipeline

4%

7 trials in Phase 3/4

Results Transparency

17%

16 of 92 completed with results

Key Signals

16 with results94% success

Data Visualizations

Phase Distribution

131Total
Not Applicable (107)
Early P 1 (4)
P 1 (7)
P 2 (6)
P 3 (1)
P 4 (6)

Trial Status

Completed92
Recruiting34
Unknown24
Active Not Recruiting11
Not Yet Recruiting6
Terminated6

Trial Success Rate

93.9%

Benchmark: 86.5%

Based on 92 completed trials

Clinical Trials (177)

Showing 20 of 20 trials
NCT05482321RecruitingPrimary

Pancreas Ultrasound Imaging in type1 Diabetes

NCT05735340Not ApplicableCompletedPrimary

Type 1 Diabetes Education and Support Study

NCT05498974RecruitingPrimary

China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes

NCT05061030Phase 1Active Not RecruitingPrimary

Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents

NCT03079921Early Phase 1CompletedPrimary

Adrenergic System in Islet Transplantation

NCT05756829Not ApplicableRecruitingPrimary

Type 1 Diabetes Virtual Self-management Education and Support

NCT07096908Phase 4RecruitingPrimary

Tirzepatide Use in People With Obesity and Type 1 Diabetes

NCT07522866Not ApplicableNot Yet RecruitingPrimary

Thrive With Type 1 Diabetes 2026

NCT05054361RecruitingPrimary

Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children

NCT04593888Not ApplicableActive Not Recruiting

Gluten Reduction and Risk of Celiac Disease

NCT07056699Phase 3Not Yet RecruitingPrimary

SGLT2i, Pioglitazone, and Ketone Production in T1D

NCT03999853Phase 1CompletedPrimary

Butyrate Adjuvant Therapy for Type 1 Diabetes

NCT03936829Not ApplicableActive Not Recruiting

Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes

NCT03648918RecruitingPrimary

Genetics Of Autoimmunity In Type I Diabetes

NCT04335656Phase 2Active Not Recruiting

Reducing Innate Inflammation in New Onset Type 1 Diabetes

NCT05258292RecruitingPrimary

Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes

NCT04336969Not ApplicableCompletedPrimary

Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D - 4T Study

NCT07434544Not ApplicableNot Yet Recruiting

Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)

NCT07087340Not ApplicableRecruitingPrimary

Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop-Genesis

NCT04289727CompletedPrimary

Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength

Scroll to load more

Research Network

Activity Timeline